Papilly is an innovation-driven health company developing digital services to prevent psychological ill health, in cooperation with leading researchers from Karolinska Institutet and the Stress Research Institute. The company is finalizing its first program and has begun commercialization of the product. Papilly continues product development, which the board says may require additional external financing; the size of any future need cannot be assessed today. The company previously communicated acceptance of a SEK 10 million convertible loan from QV Invest subject to approval at an upcoming general meeting. Papilly is listed on NASDAQ OMX First North Premier under the ticker STRS. The press release is dated 11 May 2015.

Total raised

$1M

Funding rounds

1

Latest round

Equity

Latest activity

May 2015